Mark Your Calendar for BPI US West 2025!
March 18-21, 2025San Diego Convention Center Greg DeenerChief Executive Officer at iCell Gene TherapeuticsSpeaker
Profile
| Greg Deener is CEO of iCell Gene Therapeutics. Greg has had numerous leadership roles at both large corporations (GSK, P&G) as well as earlier stage biotechs (GTx, Sucampo). iCell Gene Therapeutics was founded by Professor Yupo Ma, MD, PhD. Professor Ma is on faculty at Stony Brook as a hematopathologist. iCell began in 2014. The company model is to patent potentially best in class technology (iCell has >100 granted/allowed cell therapy patents), demonstrate the proof of concept in China and then begin full development. |
Agenda Sessions
Importance of targeting both B cells and plasma cells to safely achieve immune reset and medication-free long-term remission; iCell CAR data in autoimmune disease
, 10:30amView Session